Navigation Links
Abbott Announces Earnings Guidance for 2009
Date:1/12/2009

ABBOTT PARK, Ill., Jan. 12 /PRNewswire-FirstCall/ -- Abbott today is announcing its full-year earnings-per-share guidance for 2009 and confirming its previously issued 2008 earnings-per-share guidance of $3.31 to $3.33, excluding specified items. For 2009, the company expects earnings per share of $3.65 to $3.70 under Generally Accepted Accounting Principles (GAAP) and on a non-GAAP basis. The midpoint of this 2009 guidance reflects double-digit growth over the midpoint of 2008 earnings-per-share guidance.

Abbott's 2009 outlook includes the acquisition of Advanced Medical Optics (AMO) as announced today (see separate news release). Abbott expects the AMO transaction to be neutral to ongoing earnings per share in 2009 and accretive in 2010, both before one-time transaction-related costs, which will be provided at a later date.

Further details regarding Abbott's earnings-per-share guidance for 2009 will be provided on the company's fourth-quarter 2008 earnings conference call scheduled for Jan. 21, 2009. Including net specified items, Abbott forecasts earnings per share for the full-year 2008 under GAAP of $3.04 to $3.06. Abbott forecasts net specified items for the full-year 2008 of $0.27 per share, primarily associated with previously announced cost reduction initiatives, acquired in-process R&D, and litigation settlements. These items were partially offset primarily by previously announced one-time gains from the sale of Abbott's spine business, conclusion of the TAP joint venture, and favorable tax settlements.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 co
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences
2. Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis
3. Abbotts XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award
4. Abbott Hosts Conference Call for Third-Quarter Earnings
5. Abbott to Present at UBS Best of Americas Investment Conference
6. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
7. Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
8. Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent
9. FDA Approves Abbotts XIENCE(TM) V Drug Eluting Stent
10. Abbott Invests Additional $20M in Isis Subsidiary Ibis Biosciences
11. Abbott to Present at Goldman Sachs Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015 Bionomics Limited (ASX:BNO, ADR:BMICY) is to ... BNC105 in patients with metastatic renal cancer at the ... . The data will be presented by Dr. ... Comprehensive Cancer Center in California ... data identifies Ferritin and IL-8 as two baseline biomarkers ...
(Date:2/27/2015)... , Feb. 27, 2015  Steep Hill, the industry ... and internationally, intends to open a full service medical ... Mexico , bringing advanced scientific tools and methodology ... Steep Hill is currently the only laboratory licensed ... potency and contaminant testing in order to meet the ...
(Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading ... Kate Black as Privacy Officer and Corporate Counsel. ... state privacy laws as well as health care regulations. ... she will be responsible for reviewing, updating and enhancing ... the U.S. and abroad. She joined the company January ...
(Date:2/26/2015)... 26, 2015 Protiviti ( www.protiviti.com ), a ... the Governance Portal , designed to increase the ... (GRC) tasks across multiple business units and projects. The ... customers better align their controls with the COSO ( ... requirements. In response to client feedback, Protiviti has also ...
Breaking Biology Technology:New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 223andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
... the Genetics Policy Institute  (GPI) joined the Coalition ... curiae ("friend of the court") brief in the United States ... federal funding for human embryonic stem cell research. ... District Court and in the Court of Appeals, the latter ...
... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing, and stem ... results for the third quarter and first nine months ... Third Quarter of Fiscal 2012 Highlights ...
... a leading provider of medical IT solutions, announced the ... in One EMR/PACS/Practice Management platform at the HIMSS12 meeting ... will enable Medstreaming EMR customers to mine any EMR ... format, including DICOM. "By introducing Web ...
Cached Biology Technology:Genetics Policy Institute (GPI) Files Additional Legal Arguments in Sherley v. Sebelius Stem Cell Case 2China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012 2China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012 3China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012 4China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012 5China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012 6China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012 7China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012 8China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012 9China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012 10China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012 11China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012 12China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012 13China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012 14China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012 15Medstreaming Launches Web-Based Analytics for All in One EMR/PACS/Practice Management Platform at HIMSS 2Medstreaming Launches Web-Based Analytics for All in One EMR/PACS/Practice Management Platform at HIMSS 3
(Date:1/22/2015)... Fla. , Jan. 13, 2015  Today, FreeWavz ... technology, launched its crowdfunding campaign on Fundable, ... the build of production capacity to meet customer ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
(Date:1/22/2015)... Jan. 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD and ... reports on the recent success of the Wocket™ smart wallet at CES ... smart wallet was named as one of the "11 Hot Products at ... Products Launched At CES So Far" by Newseveryday.com and "The top 10 ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and ... the addition of the "Global Wearable Technologies ... Growth, Share, Overview, Trends and Forecast 2014-2020" ... Wearable Technologies are smart devices that can be ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... clogs waterways around the world has at least one redeeming ... and submarines. The Brazilian fern Salvinia molesta ... its surface is dotted with oddly shaped hairs that trap ... In the November 1 issue of the Journal ...
... , WASHINGTON The magnitude and depth of the ... to determine the extent and severity of ecological damage and ... of Mexico, says an interim report by the National Research ... processes -- such as fisheries production -- in addition to ...
... growing faster, suggesting that at least some forests may be ... While forests elsewhere are thinning from wildfires, insect damage ... trees in the far north of Alaska have grown more ... study has found. The health of forests globally is gaining ...
Cached Biology News:Plant with 'eggbeater' testure inspires waterproof coating 2Plant with 'eggbeater' testure inspires waterproof coating 3New report offers broad approach to assessing impacts of ecological damage 2New report offers broad approach to assessing impacts of ecological damage 3Trees on tundra's border are growing faster in a hotter climate 2Trees on tundra's border are growing faster in a hotter climate 3Trees on tundra's border are growing faster in a hotter climate 4
... The new StrepMAB-Immo coated microplates can be ... of SerAla-Strep-tag II fusion proteins for ELISA ... small amounts of such proteins are bound ... graphic on the left) and will not ...
... SPA Screening Assay, 5 x ... eliminate lengthy sample extraction procedures and ... 1.32-84.28 ng/ml (4-256 pmol/ml).Sensitivity: 0.65 ng/ml ... C. Category: Drug Screening & Cellular ...
...
Request Info...
Biology Products: